1. Home
  2. FWRD vs EDIT Comparison

FWRD vs EDIT Comparison

Compare FWRD & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$18.87

Market Cap

482.3M

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.83

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
EDIT
Founded
1981
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.3M
432.8M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
FWRD
EDIT
Price
$18.87
$2.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$37.50
$5.30
AVG Volume (30 Days)
748.8K
1.5M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
88.54
37.50
EPS
N/A
N/A
Revenue
$1,269,573,000.00
$31,937,000.00
Revenue This Year
$6.57
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.64
52 Week Low
$7.86
$1.66
52 Week High
$32.00
$4.54

Technical Indicators

Market Signals
Indicator
FWRD
EDIT
Relative Strength Index (RSI) 71.36 48.61
Support Level $17.41 $2.77
Resistance Level $23.55 $3.27
Average True Range (ATR) 0.99 0.15
MACD 0.44 0.02
Stochastic Oscillator 81.95 48.39

Price Performance

Historical Comparison
FWRD
EDIT

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: